Keyphrases
Dry Eye
60%
Sjgren's Syndrome
39%
Primary Sjgren's Syndrome
30%
Confidence Interval
26%
Clinically Significant
26%
Ocular Complications
26%
Randomized Controlled Trial
23%
Severe Dry Eye
23%
Graft-versus-host Disease (GvHD)
23%
Ocular Diseases
23%
Ocular Graft-versus-host Disease
23%
Ultracongruent Insert
23%
Longitudinal Cohort
23%
Extraglandular
17%
Ocular Surface
16%
Cyclosporine
16%
Ocular Manifestations
14%
Vision Threatening
13%
Ocular Findings
13%
Systemic Manifestations
11%
Tacrolimus
10%
Dryness
9%
Schirmer
9%
Fellow Eye
9%
Intraocular Pressure
9%
Systemic Complications
7%
March 2013
7%
Tubulointerstitial Nephritis
7%
Vasculitis
7%
Suppressant
5%
Beneficial Effects
5%
Antifibrotic
5%
Topical Application
5%
Bone Marrow Transplantation
5%
Effective Treatment
5%
Early Diagnosis
5%
Clinical Outcomes
5%
Visual Loss
5%
Calcineurin Inhibitors
5%
Anti-inflammatory Therapy
5%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
5%
Treatment Modalities
5%
Systemic Treatment
5%
Tranilast
5%
T Cells
5%
Ocular Involvement
5%
Posterior Segment Complication
5%
Local Treatment
5%
Ophthalmic Drops
5%
Medicine and Dentistry
Dry Eye
100%
Cornea Edema
23%
Randomized Controlled Trial
23%
Dexamethasone
23%
Graft Versus Host Reaction
23%
Eye Disease
23%
Amantadine
23%
Ocular Surface
20%
Vasculitis
17%
Interstitial Nephritis
17%
Cyclosporine
16%
Antinuclear Antibody
11%
Disease
11%
Patient Population
11%
Retrospective Cohort Study
11%
Intraocular Pressure
11%
La Antibody
11%
Symptom
11%
Tertiary Care
11%
Middle Age
11%
Tacrolimus
10%
Topical Corticosteroid
10%
Dystrophy
7%
Scheimpflug Imaging
7%
Arm
7%
Specular Microscopy
7%
Bone Marrow Transplantation
5%
Antifibrotic Agent
5%
Topical Drug Administration
5%
Peripheral Neuropathy
5%
Systemic Therapy
5%
Early Diagnosis
5%
Agents Acting on the Eye
5%
Anti-Inflammatory Drug
5%
Eye
5%
T Cell
5%
Local Therapy
5%
Chronic Graft Versus Host Disease
5%
Tranilast
5%
Visual Impairment
5%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Patient Referral
5%
Calcineurin Inhibitor
5%
Trinucleotide Repeat
5%
